18,343 results match your criteria Ophthalmology[Journal]


Reply.

Ophthalmology 2019 May;126(5):e40-e41

Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2018.11.030DOI Listing

Re: Keenan et al.: Progression of geographic atrophy in age-related macular degeneration (Ophthalmology. 2018;125:1913-1928).

Authors:
R Theodore Smith

Ophthalmology 2019 May;126(5):e39-e40

Mount Sinai School of Medicine, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2018.11.029DOI Listing

Re: Baek et al.: Development of topographic scoring system for identifying glaucoma in myopic eyes: a spectral-domain OCT study (Ophthalmology. 2018;125:1710-1719).

Ophthalmology 2019 May;126(5):e38

Zhongshan Hospital Affiliated to Fudan University, Center for Evidence-based Medicine of Fudan University, Shanghai, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2018.11.021DOI Listing

Reply.

Ophthalmology 2019 May;126(5):e38-e39

Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2018.11.022DOI Listing

Reply.

Ophthalmology 2019 May;126(5):e37-e38

Emory University School of Medicine, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2018.11.033DOI Listing

Re: Biousse et al.: Management of acute retinal ischemia (Ophthalmology. 2018;125:1597-1607).

Ophthalmology 2019 May;126(5):e35

Department of Ophthalmology & Visual Sciences, College of Medicine, University of Iowa, Iowa City, Iowa. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2018.11.034DOI Listing

Reply.

Ophthalmology 2019 May;126(5):e35-e36

Department of Neuro-Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2018.11.035DOI Listing

Unilateral Papilledema as the Presenting Sign of Spinal Metastases.

Ophthalmology 2019 May;126(5):763

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada; Kensington Vision and Research Centre, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2019.02.022DOI Listing

Breast Metastases Masquerading as Cellulitis.

Ophthalmology 2019 May;126(5):722

Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2019.02.019DOI Listing

Anti-Vascular Endothelial Growth Factor Injections for Diabetic Retinopathy: Continued Progress, More Questions.

Authors:
Robert N Frank

Ophthalmology 2019 May;126(5):721-722

Detroit, Michigan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2018.11.011DOI Listing

Sectoral Choroidal Hypopigmentation.

Ophthalmology 2019 May;126(5):711

Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2019.02.020DOI Listing
May 2019
1 Read

Acute Angle Closure Glaucoma in Von Hippel-Lindau Syndrome.

Ophthalmology 2019 May;126(5):691

Department of Ophthalmology, Duke Eye Center, Duke University, Durham North Carolina.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01616420193036
Publisher Site
http://dx.doi.org/10.1016/j.ophtha.2019.02.009DOI Listing
May 2019
2 Reads

In Support of Ophthalmology-Specific Patient-Reported Outcome Measures.

Ophthalmology 2019 May;126(5):690-691

Austin, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2018.12.007DOI Listing

Painful Dry Eye Symptoms: A Nerve Problem or a Tear Problem?

Authors:
Anat Galor

Ophthalmology 2019 May;126(5):648-651

Miami, Florida. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01616420183283
Publisher Site
http://dx.doi.org/10.1016/j.ophtha.2019.01.028DOI Listing
May 2019
1 Read

Strength of association between pentosan polysulfate and a novel maculopathy.

Ophthalmology 2019 Apr 17. Epub 2019 Apr 17.

Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA 30322. Electronic address:

In this retrospective study of 219 patients with interstitial cystitis at a single institution, pentosan polysulfate exposure was the sole predictor of a newly described maculopathy. All 14 affected patients had exposure to the drug. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01616420193072
Publisher Site
http://dx.doi.org/10.1016/j.ophtha.2019.04.024DOI Listing
April 2019
1 Read

Patient Satisfaction with Oral Versus Intravenous Sedation for Cataract Surgery : A Randomized Clinical Trial.

Ophthalmology 2019 Apr 16. Epub 2019 Apr 16.

Department of Ophthalmology, Boston Medical Center, Boston University School of Medicine, Boston, MA.

Purpose: To determine whether patient satisfaction with oral sedation is non-inferior to intravenous (IV) sedation for cataract surgery.

Design: A prospective, randomized, double-masked clinical trial.

Subjects: A volunteer sample of patients age 18 or older from diverse ethnic, racial, and socioeconomic backgrounds scheduled for cataract surgery. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2019.04.022DOI Listing

Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema.

BMC Ophthalmol 2019 Apr 17;19(1):92. Epub 2019 Apr 17.

Department of Ophthalmology, Gangnam Severance Hospital, Yonsei University College of Medicine, 211, Eonjuro, Gangnam-gu, Seoul, 06273, South Korea.

Background: To evaluate the efficacy of an intravitreal dexamethasone (IVD) implant (Ozurdex®) for the treatment of central retinal vein occlusion (CRVO) without macular edema (ME).

Methods: A retrospective cohort study was designed, and 20 eyes of 20 patients diagnosed with non-ischemic CRVO without ME were included. A total of 10 CRVO eyes were observed without treatment, and another 10 CRVO eyes received a single IVD injection at baseline. Read More

View Article

Download full-text PDF

Source
https://bmcophthalmol.biomedcentral.com/articles/10.1186/s12
Publisher Site
http://dx.doi.org/10.1186/s12886-019-1097-yDOI Listing
April 2019
2 Reads

Incidence of retinopathy of prematurity type 1 and type 2 in a regional Hospital of Social Security in the state of Queretaro, Mexico (2017-2018).

BMC Ophthalmol 2019 Apr 15;19(1):91. Epub 2019 Apr 15.

Instituto Mexicano de Oftalmología IAP, Circuito de Estadio de Corregidora, sin número, Santiago de Querétaro, Querétaro, Mexico.

Background: Retinopathy of prematurity (ROP), the primary cause of blindness in children, is a potential complication for 7.7% of live births in Mexico. Given that less than one-third of all neonatal intensive care units follow Mexican National ROP guidelines, there have been few reports regarding the incidences of types 1 and 2 ROP. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12886-019-1095-0DOI Listing

Clinical predictors at diagnosis of low risk histopathology in unilateral advanced retinoblastoma.

Ophthalmology 2019 Apr 12. Epub 2019 Apr 12.

Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, Toronto, Canada; Department of Ophthalmology, Faculty of Medicine, Alexandria University, Alexandria, Egypt. Electronic address:

Objective: Attempted eye salvage for unilateral (cT2b/Group D) retinoblastoma may increase risk of tumor spread compared to primary enucleation. Identification of clinical features predictive of low histopathologic risk would support safe trial salvage.

Design: Retrospective, non-comparative single-institutional observational case series PARTICIPANTS: Children with unilateral cT2b/Group D retinoblastoma (January 2008-February 2018) managed with primary enucleation at the Hospital for Sick Children (SickKids), Toronto, Canada. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2019.04.003DOI Listing

HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration.

Ophthalmology 2019 Apr 12. Epub 2019 Apr 12.

University of Bonn, Germany.

Objective: Two similarly designed, phase 3 trials (HAWK and HARRIER) compared brolucizumab, a single-chain antibody fragment that inhibits vascular endothelial growth factor-A, with aflibercept to treat neovascular age-related macular degeneration (AMD).

Design: Double-masked, multicenter, active-controlled, randomized trials.

Patients: Patients (N = 1817) with untreated, active choroidal neovascularization due to AMD in the study eye. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01616420183301
Publisher Site
http://dx.doi.org/10.1016/j.ophtha.2019.04.017DOI Listing
April 2019
5 Reads

DMEK Failure Associated with Innate Immune Activation.

Ophthalmology 2019 Apr 11. Epub 2019 Apr 11.

Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01616420193028
Publisher Site
http://dx.doi.org/10.1016/j.ophtha.2019.04.016DOI Listing
April 2019
1 Read

The Relative Impact of Patient, Physician, and Geographic Factors on Variation in Primary Rhegmatogenous Retinal Detachment Management.

Ophthalmology 2019 Apr 12. Epub 2019 Apr 12.

University of California San Francisco Department of Ophthalmology, San Francisco, CA, United States.

Objective: To evaluate geographic variation and characterize the relative contributions of patient characteristics, physician practice, and geographic region on variation in primary rhegmatogenous retinal detachment (RRD) management.

Design: Retrospective claims-based analysis PARTICIPANTS: 12,779 commercially-insured patients with incident RRD diagnosed between 2008 and 2016.

Methods: We determined whether patients underwent primary RRD repair within 60 days of diagnosis, and identified type of repair performed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2019.04.019DOI Listing

Google searches and detection of conjunctivitis epidemics worldwide.

Ophthalmology 2019 Apr 11. Epub 2019 Apr 11.

F.I. Proctor Foundation, University of California San Francisco, San Francisco, CA, USA; Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA; Department of Epidemiology and Biostatistics, Global Health Sciences, University of California San Francisco, San Francisco, CA, USA. Electronic address:

Purpose: and Objective: Epidemic and seasonal infectious conjunctivitis outbreaks can adversely impact education, workforce and economy. Yet conjunctivitis is typically not a reportable disease, potentially delaying mitigating intervention. Our study objective was to determine if conjunctivitis epidemics could be identified using Google Trends search data. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01616420183229
Publisher Site
http://dx.doi.org/10.1016/j.ophtha.2019.04.008DOI Listing
April 2019
2 Reads
6.135 Impact Factor

Update on Intraocular Lens Calculation Formulas.

Ophthalmology 2019 Apr 10. Epub 2019 Apr 10.

In a study published last year we showed the Barrett was the single most accurate IOL formula overall. Herein we report on the outcomes of new or updated formulas when run against the same datasets. Achievement of a target refractive outcome has become an integral part of cataract surgery. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01616420193028
Publisher Site
http://dx.doi.org/10.1016/j.ophtha.2019.04.011DOI Listing
April 2019
6 Reads

Simulation training in vitreoretinal surgery: a systematic review.

BMC Ophthalmol 2019 Apr 11;19(1):90. Epub 2019 Apr 11.

Department of Ophthalmology, Odense University Hospital, J.B. Winsløws Vej 4, DK-5000, Odense C, Denmark.

Background: The purpose of this study was to perform a systematic review of the current literature on simulator-based training in vitreoretinal surgery (VRS). We examined the results regarding simulated VRS and provided an overview of how the current results may be employed in VRS training. Lastly, we evaluated the quality of these results. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12886-019-1098-xDOI Listing

Visual Acuity Outcomes after Cataract Surgery: High- vs. low-volume surgeons.

Ophthalmology 2019 Apr 8. Epub 2019 Apr 8.

Aravind Eye Hospital, Madurai, Tamil Nadu, India.

Objective: Primary objective was to assess associations between annual surgeon case volume and visual acuity outcomes following cataract surgery. Secondary objectives included (i) assessing for associations between other case and patient characteristics and post-operative visual acuity outcomes and (ii) assessing for associations between annual surgeon case volume and complication rates.

Design: Database study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2019.03.033DOI Listing

A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye Disease.

Ophthalmology 2019 Apr 6. Epub 2019 Apr 6.

Virginia Eye Consultants and Eastern Virginia Medical School, Norfolk, VA, USA.

Objective: Evaluate the safety and efficacy of OTX-101, a novel aqueous nanomicellar formulation of cyclosporine (0.09%), in the treatment of subjects with dry eye disease (DED).

Design: A randomized, multicenter, vehicle-controlled, double-masked, phase 3 clinical trial. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01616420183132
Publisher Site
http://dx.doi.org/10.1016/j.ophtha.2019.03.050DOI Listing
April 2019
6 Reads

Visual and optical quality outcomes of SMILE and FS-LASIK for myopia in the very early phase after surgery.

BMC Ophthalmol 2019 Apr 8;19(1):88. Epub 2019 Apr 8.

Department of Ophthalmology, Daping Hospital of Army Medical University of PLA, No. 10 Changjiangzhi Road, Yuzhong District, Chongqing, 400042, China.

Background: Small incision lenticule extraction (SMILE) and femtosecond laser-assisted in situ keratomileusis (FS-LASIK) are frequently used to treat myopia. However, little is known about the impact on recovery of these approaches in the very early postsurgical phase (within 24 h).

Methods: To compare the efficacy of these two procedures for the treatment of myopia in the early phase after surgery, differences in visual acuity, OSI (objective scattering index), cutoff for modulation transfer function (MTF), and SR (Strehl ratio) between SMILE and FS-LASIK were evaluated at 0, 2, 4 and 24 h postoperatively using two-way analysis of variance (ANOVA). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12886-019-1096-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454732PMC

Diagnostic test accuracy of diabetic retinopathy screening by physician graders using a hand-held non-mydriatic retinal camera at a tertiary level medical clinic.

BMC Ophthalmol 2019 Apr 8;19(1):89. Epub 2019 Apr 8.

Public Health for Eye Care and Disability, International Centre for Eye Health, Clinical Research Department, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.

Background: The evidence on diagnostic test accuracy (DTA) of diabetic retinopathy (DR) screening utilising photographic studies by non-ophthalmologist personnel in low and middle-income country (LMIC) settings is scarce. We aimed to assess DTA of DR screening using a nonmydriatic hand-held digital camera by trained general physicians in a non-ophthalmic setting.

Methods: This study is a validation of a screening intervention. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12886-019-1092-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454614PMC
April 2019
1 Read

Comparison of clinical features and visual outcome between Sympathetic ophthalmia and Vogt-Koyanagi-Harada disease in Chinese Patients.

Ophthalmology 2019 Apr 5. Epub 2019 Apr 5.

Purpose: To characterize the clinical features of Sympathetic ophthalmia (SO) and make a comparison between SO and Vogt-Koyanagi-Harada (VKH) disease in Chinese patients.

Design: Retrospective case series.

Participants: A total of 131 consecutive SO and 500 VKH patients randomly selected out of those referred to our uveitis center from April 2008 to June 2018. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2019.03.049DOI Listing

Neurodevelopmental Outcomes Following Intravitreal Bevacizumab Therapy for Retinopathy of Prematurity: a prospective, case-control study.

Ophthalmology 2019 Apr 4. Epub 2019 Apr 4.

Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan. Electronic address:

Objective: To evaluate the neurodevelopmental and ocular developmental outcomes in premature children who have undergone intravitreal bevacizumab injection (IVB) for treatment of type 1 retinopathy of prematurity (ROP) DESIGN: Prospective case-control study SUBJECTS: We enrolled 3 groups of premature patients: premature children who had no history of ROP (Group 0), premature children with history of ROP without treatment (Group 1), and premature children who had received a single IVB (0.625 mg) for treatment of ROP (Group 2).

Methods: Ocular developmental assessment, including cycloplegic refractometry, axial length and Cardiff acuity, and neurodevelopmental assessment via the Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III), were performed at the age of 1 to 3 years, and were compared between groups. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2019.03.048DOI Listing
April 2019
1 Read

Unbiased Pathogen Detection and Host Gene Profiling for Conjunctivitis.

Ophthalmology 2019 Apr 3. Epub 2019 Apr 3.

Francis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, USA; Department of Ophthalmology, University of California, San Francisco, CA, USA. Electronic address:

Purpose: The etiology of conjunctivitis is often misdiagnosed. An ideal diagnostic test would identify all possible infectious causes. In this study, we apply unbiased metagenomic RNA deep sequencing (MDS) to identify pathogens causing conjunctivitis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2019.03.039DOI Listing
April 2019
1 Read

Swept-Source Optical Coherence Tomography for Evaluating the Lamina Cribrosa A Report by the American Academy of Ophthalmology.

Ophthalmology 2019 Apr 3. Epub 2019 Apr 3.

Harvard Medical School, Department of Ophthalmology, Massachusetts Eye & Ear, Glaucoma Service, Boston, Massachusetts.

Objective: To review the published literature on the use of swept-source optical coherence tomography (SS-OCT) for evaluating the lamina cribrosa in glaucoma.

Methods: A PubMed and Cochrane Library literature search initially conducted on March 3, 2017 and updated on June 26, 2018 yielded a total of 64 articles. Articles that were reviews or that were not published in English were excluded, and 29 were found to fit the inclusion criteria. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2019.03.044DOI Listing
April 2019
1 Read

Monocanalicular Stents in Eyelid Lacerations A Report by the American Academy of Ophthalmology.

Ophthalmology 2019 Apr 3. Epub 2019 Apr 3.

Vanderbilt Eye Institute, Vanderbilt University, Nashville, Tennessee.

Purpose: To determine the efficacy and complication rates of monocanalicular stents in the setting of canalicular lacerations.

Methods: A literature search was performed in May 2018 in the PubMed database to identify all English-language reports of monocanalicular stenting to address canalicular lacerations. Studies that did not include at least 10 patients with at least 3 months of follow-up evaluation after surgery were excluded. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2019.03.045DOI Listing
April 2019
2 Reads

The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial.

Ophthalmology 2019 Apr 1. Epub 2019 Apr 1.

Genentech, Inc., South San Francisco, California.

Purpose: To evaluate the safety and efficacy of the Port Delivery System with ranibizumab (PDS) for neovascular age-related macular degeneration (nAMD) treatment.

Design: Phase 2, multicenter, randomized, active treatment-controlled clinical trial.

Participants: Patients diagnosed with nAMD within 9 months who had received ≥ 2 prior anti-vascular endothelial growth factor intravitreal injections and were responsive to treatment. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01616420183332
Publisher Site
http://dx.doi.org/10.1016/j.ophtha.2019.03.036DOI Listing
April 2019
12 Reads

Longitudinal Retinal Perfusion Status in Eyes with Diabetic Macular Edema Receiving Intravitreal Aflibercept or Laser in VISTA study.

Ophthalmology 2019 Apr 1. Epub 2019 Apr 1.

Regeneron Pharmaceuticals, Inc., Tarrytown, New York, United States.

Purpose: To evaluate changes in retinal perfusion status with intravitreal aflibercept injection (IAI) and laser treatment in the phase 3 VISTA study of patients with diabetic macular edema (DME).

Design: Post-hoc analysis of a double-masked, randomized, active-controlled, phase 3 trial.

Participants: Patients with center-involved DME in the study eye. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2019.03.040DOI Listing
April 2019
1 Read

Adjunctive dexamethasone implant in patients with atopic dermatitis and retinal detachment undergoing vitrectomy and silicone oil tamponade: an interventional case series.

BMC Ophthalmol 2019 Apr 3;19(1):86. Epub 2019 Apr 3.

Department of Ophthalmology, University of Ulsan, College of Medicine, Asan Medical Center, 88, Olympic-ro 43-Gil, Songpa-gu, Seoul, 05505, Korea.

Background: To report the clinical course and outcomes of adjunctive dexamethasone implants in patients with atopic dermatitis (AD) and retinal detachment (RD) undergoing vitrectomy and silicone oil tamponade.

Methods: This retrospective, interventional case series included AD patients with RD and various degrees of proliferative vitreoretinopathy (PVR) who were scheduled to undergo vitrectomy. Following total vitrectomy and retinopexy, silicone oil tamponade was performed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12886-019-1094-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448232PMC
April 2019
2 Reads
1.075 Impact Factor

Epidemiology and clinical features of viral anterior uveitis in southern Taiwan-diagnosis with polymerase chain reaction.

BMC Ophthalmol 2019 Apr 3;19(1):87. Epub 2019 Apr 3.

Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, No.123, Dapi Rd., Niaosong Dist, Kaohsiung, 833, Taiwan.

Background: To report the epidemiology and clinical features of viral anterior uveitis in patients in southern Taiwan.

Methods: A retrospective, case series study. HLA-B27 negative anterior uveitis patients with increased intraocular pressure or corneal edema seen at Kaohsiung Chang Gung Memorial Hospital from January 1, 2007 to January 31, 2018 had their aqueous sent for polymerase chain reaction analysis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12886-019-1093-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448235PMC
April 2019
2 Reads

Individualized penetrating keratoplasty using edge-trimmed glycerol-preserved donor corneas for perforated corneal ulcers.

BMC Ophthalmol 2019 Apr 2;19(1):85. Epub 2019 Apr 2.

Department of Ophthalmology, Tongji Hospital, Tongji University School of Medicine, 389 Xincun Road, Shanghai, 200065, China.

Purpose: To report a surgical technique and the surgical outcomes of individualized penetrating keratoplasty (PK) using edge-trimmed glycerol-preserved donor corneas for perforated corneal ulcers.

Methods: Fourteen perforated eyes from 14 patients who underwent individualized PK using edge-trimmed glycerol-preserved donor corneas, were included in the retrospective study. The perforations were mainly 1-2 mm in size except for one that was 2. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12886-019-1091-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444435PMC
April 2019
1 Read

Imaging Infant Retinal Vasculature with OCT Angiography.

Ophthalmol Retina 2019 Jan 26;3(1):95-96. Epub 2018 Jul 26.

Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oret.2018.06.017DOI Listing
January 2019

Activated Protein C for Ischemic Central Retinal Vein Occlusion: One-Year Results.

Ophthalmol Retina 2019 Jan 25;3(1):93-94. Epub 2018 Jul 25.

Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan.

Intravitreally administered activated protein C in 10 eyes with ischemic central retinal vein occlusion significantly improved macular edema; in 5 eyes, the reperfusion of the retinal nonperfused areas exceeded 50% of baseline. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S24686530183041
Publisher Site
http://dx.doi.org/10.1016/j.oret.2018.07.012DOI Listing
January 2019
8 Reads

The Natural History of Congenital X-Linked Retinoschisis and Conversion between Phenotypes over Time.

Ophthalmol Retina 2019 Jan 24;3(1):77-82. Epub 2018 Aug 24.

Associated Retinal Consultants, William Beaumont Hospital, Royal Oak, Michigan; William Beaumont School of Medicine, Oakland University, Rochester, Michigan. Electronic address:

Purpose: To evaluate the natural history of congenital X-linked retinoschisis (CXLRS) and to assess disease stability or progression over time.

Design: Retrospective case series at a single-center, tertiary care, pediatric retina practice.

Participants: One hundred two eyes of 51 patients with CXLRS. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oret.2018.08.006DOI Listing
January 2019

New Scleral Depressor Marker for Retinal Detachment Surgery.

Ophthalmol Retina 2019 Jan 22;3(1):73-76. Epub 2018 Aug 22.

Department of Ophthalmology, Rudolf Foundation Hospital, Vienna, Austria; Karl Landsteiner Institute for Retinal Research and Imaging, Vienna, Austria; Eye Center Donaustadt, Sigmund Freud University, Vienna, Austria.

Purpose: To report the efficacy of the use of a new scleral depressor marker during scleral buckling surgery for retinal detachment.

Design: Noncomparative, consecutive case series study.

Participants: Eleven patients (11 eyes) with rhegmatogenous retinal detachment who underwent scleral buckling surgery performed by 2 experienced vitreoretinal surgeons. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oret.2018.08.005DOI Listing
January 2019
2 Reads

Traumatic Maculopathy with Massive Subretinal Hemorrhage after Closed-Globe Injuries: Associated Findings, Management, and Visual Outcomes.

Ophthalmol Retina 2019 Jan 25;3(1):53-60. Epub 2018 Aug 25.

Department of Ophthalmology, Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Taoyuan, Taiwan.

Purpose: To investigate the visual outcomes of patients with traumatic maculopathy and massive subretinal hemorrhage (SRH) after closed-globe injury.

Design: Retrospective, noncomparative, and interventional case series.

Participants: Twenty-four patients with traumatic maculopathy and massive SRH after closed-globe injury. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oret.2018.08.007DOI Listing
January 2019
2 Reads

Ocriplasmin Treatment Leads to Symptomatic Vitreomacular Adhesion/Vitreomacular Traction Resolution in the Real-World Setting: The Phase IV ORBIT Study.

Ophthalmol Retina 2019 Jan 25;3(1):32-41. Epub 2018 Jul 25.

California Retina Consultants, Santa Barbara, California; California Retina Research Foundation, Santa Barbara, California.

Purpose: To evaluate clinical outcomes and safety up to 12 months after ocriplasmin injection for the treatment of patients with symptomatic vitreomacular adhesion (VMA)/vitreomacular traction (VMT) in a real-world setting.

Design: The Phase IV Ocriplasmin Research to Better Inform Treatment (ORBIT) trial (NCT02079883) was a Phase IV multicenter, prospective, observational study.

Participants: Patients aged ≥18 years with symptomatic VMA/VMT treated with ocriplasmin. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oret.2018.07.011DOI Listing
January 2019
2 Reads

The Incidence of Neovascularization in the Fellow Eye of Patients with Unilateral Choroidal Lesion: A Survival Analysis.

Ophthalmol Retina 2019 Jan 18;3(1):27-31. Epub 2018 Aug 18.

Eye Clinic, Department of Biomedical and Clinical Science "Luigi Sacco," University of Milan, Luigi Sacco Hospital, Milan, Italy. Electronic address:

Purpose: To compare the difference in the rate of survival of unaffected fellow eyes between choroidal neovascularization (CNV) in the first eyes and retinal angiomatous proliferation (RAP) in the first eyes.

Design: Cohort retrospective study.

Participants: A total of 329 consecutive patients enrolled in our Eye Clinic between February 2006 and November 2014 were involved in the study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oret.2018.08.003DOI Listing
January 2019
2 Reads

A Multinational Comparison of Anti-Vascular Endothelial Growth Factor Use: The United States, the United Kingdom, and Asia-Pacific.

Ophthalmol Retina 2019 Jan 9;3(1):16-26. Epub 2018 Aug 9.

Department of Ophthalmology, New York University School of Medicine, New York, New York.

Purpose: A comparison of anti-vascular endothelial growth factor (anti-VEGF) medication use across multiple countries.

Clinical Relevance: Anti-VEGF medication use is now considered first-line treatment for numerous retinal diseases globally. Exploring medication choices, costs within each healthcare system, policy challenges, emerging treatments, and patient access all provide insight into a newly recognized and major public health issue. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oret.2018.08.002DOI Listing
January 2019
2 Reads

Pneumatic Retinopexy Experience and Outcomes of Vitreoretinal Fellows in the United States: A Multicenter Study.

Ophthalmol Retina 2019 Feb 20;3(2):140-145. Epub 2018 Sep 20.

Department of Ophthalmology & Vision Science, University of California, Davis, Sacramento, CA.

Objective: To evaluate the outcomes of patients undergoing pneumatic retinopexy (PR) performed by vitreoretinal fellows at 6 academic centers in the United States.

Design: Retrospective, multicenter, consecutive case series.

Participants: 483 patients with primary retinal detachments who underwent PR by 49 vitreoretinal fellows from 6 U. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oret.2018.09.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435286PMC
February 2019
3 Reads